USFDA issues EIR to Natco Pharma’s Hyderabad API division

25 Jul 2025 Evaluate

U.S. Food and Drug Administration (USFDA) has issued Establishment Inspection Report (EIR) to Natco Pharma’s Active Pharmaceutical Ingredient (API) division located in Mekaguda, Hyderabad, India on July 24, 2025. 

USFDA had conducted an inspection at said facility from June 9, 2025 to June 13, 2025.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

1000.60 22.30 (2.28%)
30-Mar-2026 11:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1778.90
Dr. Reddys Lab 1259.40
Cipla 1226.90
Zydus Lifesciences 882.60
Lupin 2303.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×